Contrasting genetic predisposition and diagnosis in psychiatric disorders: A multi-omic single-nucleus analysis of the human OFC

• DOI: 10.1126/sciadv.adq2290
• Publication Date: 2025-03-07T18:59:41Z
• Authors: Nathalie Gerstner; Anna S. Fröhlich; Natalie Matosin; Miriam Gagliardi; Cristiana Cruceanu; Maik Ködel; Monika Rex-Haffner; Xinming Tu; Sara Mostafavi; Michael J. Ziller; Elisabeth B. Binder; Janine Knauer-Arloth

Psychiatric disorders like schizophrenia, bipolar disorder, and major depressive disorder exhibit substantial genetic and clinical overlap. However, their molecular architecture remains elusive due to their polygenic nature and complex brain cell interactions. We integrated clinical data with genetic susceptibility to investigate gene expression and chromatin accessibility in the orbitofrontal cortex of 92 postmortem human brain samples at the single-nucleus (sn) level. Using snRNA-seq and snATAC-seq, we analyzed ~800,000 and 400,000 nuclei, respectively. We observed cell-type–specific dysregulation related to clinical diagnosis and genetic risk. Dysregulation in gene expression and chromatin accessibility associated with diagnosis was pronounced in excitatory neurons. Conversely, genetic risk predominantly affected glial and endothelial cells. Notably, INO80E and HCN2 genes exhibited dysregulation in excitatory neurons’ superficial layers 2/3 influenced by schizophrenia polygenic risk. This study unveils the complex genetic and epigenetic landscape of psychiatric disorders, emphasizing the importance of cell-type–specific analyses in understanding their pathogenesis and contrasting genetic predisposition with clinical diagnosis.